COMMUNIQUÉS West-GlobeNewswire

Advanced Proteome Therapeutics Updates its Activities During the 3rd Quarter, FY 2018

01/05/2018 - 14:30

VANCOUVER, British Columbia, May 01, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“ APC ” or the “ Company ”) (TSXV:APC) (FSE:0E8) is pleased to provide an update of progress during the third [...]

Golden Leaf Holdings Opens New Chalice Farms Dispensary in Happy Valley, Oregon

01/05/2018 - 14:30

PORTLAND, Ore., May 01, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company and dispensary operator built around recognized [...]

Genetic Technologies Announces Grant from NHMRC Awarded to University of Melbourne to Substantially Improve Breast Cancer Risk Prediction and Increase Accessibility

01/05/2018 - 11:30

MELBOURNE, Australia, May 01, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq: GENE ) (“Company”), a diversified molecular diagnostics company embracing blockchain technologies across genomic [...]

Trading by management and close relations of management

01/05/2018 - 10:26

Read the full announcement in the attached file Attachment 2018_21_Trading_by_management_EN

Shire plc : Rule 2.9 Announcement

01/05/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 1 May 2018 Shire [...]

Motif Bio REVIVE-2 Phase 3 Study Results with Iclaprim Published in Peer-reviewed Journal, Antimicrobial Agents and Chemotherapy

01/05/2018 - 08:00

Iclaprim met the primary endpoint Iclaprim was well tolerated in the study, with no nephrotoxicity observed Additional data from the previously announced results are included in the publication NEW YORK, May 01, 2018 ( [...]

DBV Technologies to Attend Upcoming Investor Conferences

01/05/2018 - 07:31

Montrouge, France, May 1, 2018 DBV Technologies to Attend Upcoming Investor Conferences DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, [...]

DBV Technologies Invitée à Présenter lors des prochaines Conférences Investisseurs

01/05/2018 - 07:31

Montrouge, France, le 1 mai (7H30 CET), 2018 DBV Technologies Invitée à Présenter lors des prochaines Conférences Investisseurs DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq : DBVT), société [...]

AveXis Provides Update on Proposed Acquisition by Novartis AG

01/05/2018 - 07:07

CHICAGO, May 01, 2018 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, [...]

Novartis provides update on proposed acquisition of AveXis

01/05/2018 - 07:01

Basel, May 1 , 2018 - Novartis AG (NYSE: NVS) ("Novartis") today announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "HSR Act") applicable to Novartis' cash [...]

Medibio Launches Global Corporate Mental Health Product

01/05/2018 - 06:00

Release of first commercially available mental health technology product Notable existing support from key Australian companies Provide organizations with cost savings by reducing mental health burden SYDNEY, Australia [...]

Lexington Releases Audited Consolidated Financial Statements

01/05/2018 - 02:18

VANCOUVER, British Columbia, April 30, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, has released its audited [...]

MacroGenics Announces Date of First Quarter 2018 Financial Results Conference Call

01/05/2018 - 00:30

ROCKVILLE, MD, April 30, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX) today announced that on Monday, May 7, 2018, the Company will release its financial results for the quarter ended March 31, 2018. The [...]

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01/05/2018 - 00:00

CAMBRIDGE, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to [...]

Immucor Announces FDA Clearance for Echo Lumena(TM); Next Generation, Fully Automated Instrument Powers Smaller to Mid-Volume Labs

30/04/2018 - 23:25

Faster, clearer blood compatibility results now available NORCROSS, Ga., April 30, 2018 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that its next [...]

Helix BioPharma Corp. Closes Private Placement

30/04/2018 - 23:05

RICHMOND HILL, Ontario, April 30, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP ) (FSE:HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]

Forward Pharma Reports Full-Year 2017 Financial and Operational Results

30/04/2018 - 22:40

COPENHAGEN, Denmark, April 30, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq: FWP ) (“We” or “Forward” or the “Company”), today reported financial results for the year ended December 31, 2017. Net income for the [...]

Flexion Therapeutics to Report First-Quarter 2018 Financial Results on May 8, 2018

30/04/2018 - 22:30

BURLINGTON, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced that it will report its first-quarter 2018 financial results after the close of the U.S. financial markets [...]

Portola Pharmaceuticals to Announce First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 9, 2018

30/04/2018 - 22:30

SOUTH SAN FRANCISCO, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA ) announced today that it will host a webcast and conference call to discuss the Company’s financial results [...]